Lisinopril Tablets USP — Class II drug recall D-1347-2015
Terminated recall by Wockhardt Usa Inc., reported 2015-08-26, distributed nationwide. CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
| Recall number | D-1347-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Wockhardt Usa Inc., Parsippany, NJ, United States |
| Recall initiated | 2015-07-29 |
| Classified | 2015-08-19 |
| Reported by FDA | 2015-08-26 |
| Terminated | 2017-04-12 |
| Distributed | Nationwide (US) |
| Quantity | 3,378 bottles |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00364679941065 |
| NDC | 64679-0941-06 |
| Lot numbers | 10/15, 11/15, DM13219, DM13428 |
Product
Lisinopril Tablets USP, 20 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 94106 5, NDC 64679-941-06.
Reason for recall
CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1347-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.